SupplySide West: On Record With FDA's Cara Welch

FDA continues to inspect dietary supplement firms to ensure compliance with manufacturing regulations, but an agency official said the level of noncompliance today—and ignorance of requirements adopted nearly a decade ago—are inexcusable.

FDA continues to inspect dietary supplement firms to ensure compliance with manufacturing regulations, but an agency official said the level of noncompliance today—and ignorance of requirements adopted nearly a decade ago—are inexcusable.

In this video recorded at SupplySide West in Las Vegas, Cara Welch, Ph.D., senior advisor to FDA’s Office of Dietary Supplement Programs, discussed some important regulatory matters, including:

-          Compliance with cGMPs (current Good Manufacturing Practices);

-          And the 2016 draft new dietary ingredient (NDI) guidance.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish